HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmetics Industry Has Stake In TPP Fast-Tracking – PCPC

This article was originally published in The Rose Sheet

Executive Summary

Fast-track legislation headed for House and Senate floor votes would help expedite passage of the Trans-Pacific Partnership, the first free-trade deal to include a cosmetics annex. The Personal Care Products Council expects the cosmetics provisions to “increase export opportunities for our industry by lowering trade and regulatory barriers and providing more global consistency in standards, testing and labeling requirements.”

You may also be interested in...



DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss

The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.

Unfairly Hit By Influencer Assassins? Now Could Be Your Chance To Engage The FTC

Brands unfairly attacked by powerful influencers could raise the subject with the US Federal Trade Commission, which is asking for comments on its “Endorsement Guides."  

50 Years Later, FDA And Cosmetics Industry At Odds Again Over Asbestos

The Personal Care Products Council says talc-testing methods in the cosmetics industry must distinguish between carcinogenic asbestos and harmless non-asbestiform minerals, recalling its position against the FDA’s stab at rulemaking in 1973. However, the FDA is now arguing that elongate mineral particles of respirable dimensions are inherently dangerous, regardless of other considerations.

UsernamePublicRestriction

Register

RS019469

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel